chr10-124681902-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_014661.4(FAM53B):c.611G>A(p.Cys204Tyr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000112 in 1,613,806 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_014661.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
FAM53B | NM_014661.4 | c.611G>A | p.Cys204Tyr | missense_variant | 4/5 | ENST00000337318.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
FAM53B | ENST00000337318.8 | c.611G>A | p.Cys204Tyr | missense_variant | 4/5 | 1 | NM_014661.4 | P1 | |
FAM53B | ENST00000280780.6 | c.611G>A | p.Cys204Tyr | missense_variant | 4/5 | 1 | |||
FAM53B | ENST00000392754.7 | c.611G>A | p.Cys204Tyr | missense_variant | 4/5 | 2 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000394 AC: 6AN: 152258Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000201 AC: 5AN: 249086Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135080
GnomAD4 exome AF: 0.00000821 AC: 12AN: 1461548Hom.: 0 Cov.: 32 AF XY: 0.00000275 AC XY: 2AN XY: 727060
GnomAD4 genome AF: 0.0000394 AC: 6AN: 152258Hom.: 0 Cov.: 33 AF XY: 0.0000672 AC XY: 5AN XY: 74386
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 15, 2024 | The c.611G>A (p.C204Y) alteration is located in exon 4 (coding exon 3) of the FAM53B gene. This alteration results from a G to A substitution at nucleotide position 611, causing the cysteine (C) at amino acid position 204 to be replaced by a tyrosine (Y). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at